Evidence map›Paper›PMID 34770918›Full record

ArticleMolecules (Basel, Switzerland)2021

Design and Characterization of Maltoheptaose-

Marcos Antonio Villetti, Adryana Rocha Clementino, Ilaria Dotti, Patricia Regina Ebani, Eride Quarta, Francesca Buttini, Fabio Sonvico, Annalisa Bianchera, Redouane Borsali

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 10 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Marcos Antonio VillettiLaboratório de Espectroscopia e Polímeros (Lepol), Departamento de Física, Universidade Federal de Santa Maria, Santa Maria 97105-900, Brazil.
Adryana Rocha ClementinoBiopharmanet-TEC, University of Parma, 43124 Parma, Italy.
Ilaria DottiDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.
Patricia Regina EbaniLaboratório de Espectroscopia e Polímeros (Lepol), Departamento de Física, Universidade Federal de Santa Maria, Santa Maria 97105-900, Brazil.
Eride QuartaDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.ORCID 0000-0003-0215-2350
Francesca ButtiniBiopharmanet-TEC, University of Parma, 43124 Parma, Italy.ORCID 0000-0002-4472-4823
Fabio SonvicoBiopharmanet-TEC, University of Parma, 43124 Parma, Italy.ORCID 0000-0001-7372-1456
Annalisa BiancheraBiopharmanet-TEC, University of Parma, 43124 Parma, Italy.ORCID 0000-0002-3160-9586
Redouane BorsaliDepartment of Chemistry, University Grenoble Alpes, CNRS, CERMAV, 38000 Grenoble, France.
University of Parma · ITUniversidade Federal de Santa Maria · BRCentre National de la Recherche Scientifique · FR

Funding

CAPES/Print 88881.310412/2018-01National Council for Scientific and Technological Development 308001/2020-6
6 · The paper itself

Abstract

Tamoxifen citrate (TMC), a non-steroidal antiestrogen drug used for the treatment of breast cancer, was loaded in a block copolymer of maltoheptaose-

Indexed as

Drug Delivery SystemsGlucansPolystyrenesBreast NeoplasmsCell Line, TumorCell SurvivalChemical PhenomenaChromatography, High Pressure LiquidDose-Response Relationship, DrugDrug CarriersDrug CompoundingDrug LiberationFemaleHumansKineticsModels, TheoreticalDrug CarriersGlucansmaltoheptaosePolystyrenesSelective Estrogen Receptor ModulatorsTamoxifenblock copolymerbreast cancercytotoxicitytamoxifen citrate

Identifiers

PMID34770918
PMCPMC8587208
OpenAlexW3209082155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.